MedTrace Logo

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™

NCT02221232 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2016-07-18

No results posted yet for this study

Summary

The purpose of this pilot study is to evaluate antimicrobial properties of a single test product, a vehicle product and a reference product applied in two different areas when used as a patient preoperative skin preparation.

Conditions

  • Surgical Site Infection

Interventions

DRUG

Chloraprep

Apply topically.

DRUG

ZuraPrep

Apply topically.

DRUG

ZuraPrep Vehicle

Apply topically.

Sponsors & Collaborators

  • Zurex Pharma, Inc.

    lead INDUSTRY

Principal Investigators

  • Chris Beausoleil · BioScience Laboratories, Inc.

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02221232 on ClinicalTrials.gov